Request for Covid-19 Impact Assessment of this Report
Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Oct 2013 - Mar 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)
Introduction
Slide 5: Coronary stents - Uses, Characteristics and Types
Slide 6: Development of Coronary Stents
Market Overview
Slide 7: Angioplasties - Overview and Number of Procedures Performed in India (2008 - 2018e)
Slide 8: Angioplasties - Segmentation (Age-Wise; 2008 - 2013 & Gender-Wise; 2008 -2013)
Slide 9: Angioplasties - Segmentation (Based on Vessels Treated; 2009 - 2013 & Segregation of Centers Based on Number of Angioplasties Performed Each Year; 2009, 2010, 2011, 2013)
Slide 10: Coronary Stents - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e & Volume-Wise; 2012 - 2018e)
Slide 11: Drug-Eluting Stents - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e & Volume-Wise; 2012 - 2018e)
Slide 12: Bare Metal Stents - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e & Volume-Wise; 2012 - 2018e)
Slide 13: Bioabsorbable Stents - Market Overview, Market Size & Growth (Value-Wise; 2013 - 2018e & Volume-Wise; 2013e - 2018e)
Slide 14: Coronary Stents - Price Trends
Drivers & Challenges
Slide 15: Drivers and Challenges - Summary
Slide 16-20: Drivers
Slide 21-22: Challenges
Government Involvement
Slide 23: Organizational Structure of Regulatory Bodies
Slide 24-25: Regulatory Bodies
Slide 26-29: Regulatory Policies
Slide 30: Process of Obtaining License for Manufacturing Medical Device Regulated as Drugs in India
Slide 31-33: Requirements for Grant of License for Manufacture of Medical Devices in India
Slide 34: Process of Obtaining Registration for Import of Medical Device Regulated as Drugs in India
Slide 35-39: Documents Required for the Registering Medical Devices for Import into India
Competitive Landscape
Slide 40-42: Entry Barriers
Slide 43: Porter's Five Forces Analysis
Slide 44: Competition Overview, Market Share of Companies (Volume-Wise; 2013)
Slide 45: Sale of Coronary Stents by Various Companies (2013)
Slide 46-49: Competitive Benchmarking
Slide 50-98: Major Companies
Buyer Details
Slide 99: List of Top 10 Hospitals Buying Coronary Stents in India
Slide 100-129: Major Buyers
Slide 130: Other Major Purchasers of Stents
Recent Developments
Slide 131: Major Recent Developments in the Market
Strategic Recommendation
Slide 132-133: Key Recommendations
Slide 134: Opportunities by Geography
Appendix
Slide 135: Key Ratios Description
Slide 136: Sources of Information
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...